AJAlan E. Jones

Alan E. Jones

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alan E. Jones has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Reply to Letters Regarding Article, “Relationship Between Supranormal Oxygen Tension and Outcome After Resuscitation From Cardiac Arrest”

    by J. Hope Kilgannon, Stephen Trzeciak, Joseph E. Parrillo, R. Phillip Dellinger, Barry Milcarek, Krystal Hunter, Alan E. Jones, Nathan I. Shapiro

  • The impact of emergency medical services on the ED care of severe sepsis

    by Jonathan R. Studnek, Melanie R. Artho, Craymon L. Garner, Alan E. Jones


  • Cost-effectiveness of an emergency department-based early sepsis resuscitation protocol*

    by Alan E. Jones, Jennifer L. Troyer, Jeffrey A. Kline

    Guidelines recommend that sepsis be treated with an early resuscitation protocol such as early goal-directed therapy. Our objective was to assess the cost-effectiveness of implementing early goal-directed therapy as a routine protocol. Prospective before and after study. Large urban hospital emergency department with >110,000 visits/yr. The target population was patients with consensus criteria for septic shock. We excluded those with age <18 yrs, no aggressive care desired, or need for immediate surgery. Clinical and cost data were prospectively collected on two groups: 1) patients from 1 yr before; and 2) 2 yrs after implementing early goal-directed therapy as standard of care. Before phase patients received nonprotocolized care at attending discretion. The primary outcomes were 1-yr mortality, discounted life expectancy, and quality-adjusted life-years. Using costs and quality-adjusted life-years, we constructed an incremental cost-effectiveness ratio and performed a net monetary benefit analysis, producing the probability that the intervention was cost-effective given different values for the willingness to pay for a quality-adjusted life-year. Two hundred eighty-five subjects, 79 in the before and 206 in the after phases, were enrolled. Treatment with early goal-directed therapy was associated with an increased hospital cost of $7,028 and an increase in both discounted sepsis-adjusted life expectancy and quality-adjusted life years of 1.5 and 1.3 yrs, respectively. Early goal-directed therapy use was associated with a cost of $5,397 per quality-adjusted life-years gained and the net monetary benefit analysis indicates a 98% probability (p = .038) that early goal-directed therapy is cost-effective at a willingness to pay of $50,000 per quality-adjusted life-years. Implementation of early goal-directed therapy in the emergency department care of patients with severe sepsis is cost-effective.


  • Lactate Clearance and Central Venous Oxygen Saturation in Early Sepsis—Reply

    by Alan E. Jones, Jeffrey A. Kline, Stephen Trzeciak

    In Reply: We have 2 responses to the concerns of Drs Sauneuf and Charbonneau that the population we enrolled in our study may have lower illness severity than might be predicted in a severe sepsis trial and is different than that enrolled in the study by Rivers et al.1 First, we based our inclusion criteria on the same set of criteria used in the study by Rivers et al: (1) suspected infection, (2) two or more systemic inflammatory response criteria, and (3) evidence of hypoperfusion manifested by either refractory hypotension (systolic blood pressure 2 to identify patients in need of goal-directed resuscitation and are the same inclusion criteria being used by the multicenter ProCESS trial and the ARISE trials. Moreover, these inclusion criteria produced a population that manifested severity of illness and organ dysfunction scores with a greater than 30% predicted mortality. Thus, we believe that this study population is an accurate contemporaneous representation of severe sepsis and septic shock populations encountered in US emergency departments.

  • Open Access

    Etiology of Illness in Patients with Severe Sepsis Admitted to the Hospital from the Emergency Department

    by Alan C. Heffner, James M. Horton, Michael R. Marchick, Alan E. Jones

    Background. Patients identified with sepsis in the emergency department often are treated on the basis of the presumption of infection; however, vari


  • Open Access

    One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study

    by Michael A Puskarich, Michael R Marchick, Jeffrey A Kline, Michael T Steuerwald, Alan E Jones

    Introduction: Early structured resuscitation of severe sepsis has been suggested to improve short term mortality; however, no previous study has examined the long-term effect of this therapy. We sought to determine one year outcomes associated with implementation of early goal directed therapy (EGDT) in the emergency department (ED) care of sepsis. Methods: We performed a longitudinal analysis of a prospective before and after study conducted at a large urban ED. Adult patients were enrolled if they had suspected infection, 2 or more systemic inflammatory response criteria, and either systolic blood pressure (SBP) 4 mM. Exclusion criteria were: age P < 0.001) and higher sequential organ failure assessment score (7 vs. 5, P = 0.0004). The primary outcome of 1 year mortality was observed in 39/79 (49%) pre-implementation subjects and 77/206 (37%) post-implementation subjects (difference 12%; P = 0.04). Conclusions: Implementation of EGDT for the treatment of ED patients with severe sepsis and septic shock was associated with significantly lower mortality at one year.


  • Sepsis-Induced Tissue Hypoperfusion

    by Alan E. Jones, Michael A. Puskarich


  • Effect of Glucose—Insulin—Potassium Infusion on Mortality in Critical Care Settings: A Systematic Review and Meta‐Analysis

    by Michael A. Puskarich, Michael S. Runyon, Stephen Trzeciak, Jeffrey A. Kline, Alan E. Jones

    This study seeks to measure the treatment effect of glucose—insulin—potassium (GIK) infusion on mortality in critically ill patients. A systematic review of randomized controlled trials is conducted, comparing GIK treatment with standard care or placebo in critically ill adult patients. The primary outcome variable is mortality. Two authors independently extract data and assess study quality. The primary analysis is based on the random effects model to produce pooled odds ratios (ORs) with 95% confidence intervals (CIs). The search yields 1720 potential publications; 23 studies are included in the final analysis, providing a sample of 22 525 patients. The combined results demonstrate no heterogeneity (P = .57, I2 = 0%) and no effect on mortality (OR = 1.02; 95% CI, 0.93–1.11) with GIK treatment. No experimental studies of shock or sepsis populations are identified. This meta‐analysis finds that there is no mortality benefit to GIK infusion in critically ill patients; however, study populations are limited to acute myocardial infarction and cardiovascular surgery patients. No studies are identified using GIK in patients with septic shock or other forms of circulatory shock, providing an absence of evidence regarding the effect of GIK as a therapy in patients with shock.


  • Top Cited Papers

    The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation*

    by Alan E. Jones, Stephen Trzeciak, Jeffrey A. Kline

    Objectives: Organ failure worsens outcome in sepsis. The Sequential Organ Failure Assessment (SOFA) score numerically quantifies the number and severity of failed organs. We examined the utility of the SOFA score for assessing outcome of patients with severe sepsis with evidence of hypoperfusion at the time of emergency department (ED) presentation. Design: Prospective observational study. Setting: Urban, tertiary ED with an annual census of >110,000. Patients: ED patients with severe sepsis with evidence of hypoperfusion. Inclusion criteria: suspected infection, two or more criteria of systemic inflammation, and either systolic blood pressure <90 mm Hg after a fluid bolus or lactate ≥4 mmol/L. Exclusion criteria: age <18 years or need for immediate surgery. Interventions: SOFA scores were calculated at ED recognition (T0) and 72 hours after intensive care unit admission (T72). The primary outcome was in-hospital mortality. The area under the receiver operating characteristic curve was used to evaluate the predictive ability of SOFA scores at each time point. The relationship between Δ SOFA (change in SOFA from T0 to T72) was examined for linearity. Results: A total of 248 subjects aged 57 ± 16 years, 48% men, were enrolled over 2 years. All patients were treated with a standardized quantitative resuscitation protocol; the in-hospital mortality rate was 21%. The mean SOFA score at T0 was 7.1 ± 3.6 points and at T72 was 7.4 ± 4.9 points. The area under the receiver operating characteristic curve of SOFA for predicting in-hospital mortality at T0 was 0.75 (95% confidence interval 0.68–0.83) and at T72 was 0.84 (95% confidence interval 0.77–0.90). The Δ SOFA was found to have a positive relationship with in-hospital mortality. Conclusions: The SOFA score provides potentially valuable prognostic information on in-hospital survival when applied to patients with severe sepsis with evidence of hypoperfusion at the time of ED presentation.